Search Results

You are looking at 51 - 60 of 85 items for :

  • Refine by Access: All content x
Clear All
Open access

Ivar Følling, Anna B Wennerstrøm, Tor J Eide, and Hilde Loge Nilsen

stimulation of glucagon-like peptide 1 receptors (GLP1R). GLP1R expression/protein has been found on phaeochromocytoma cells ( 42 ) and tumours ( 43 ), but whether they function normally or if they are expressed on cells positive for anti-insulin staining is

Open access

Caishun Zhang, Junhua Yuan, Qian Lin, Manwen Li, Liuxin Wang, Rui Wang, Xi Chen, Zhengyao Jiang, Kun Zhu, Xiaoli Chang, Bin Wang, and Jing Dong

including PYY ( 17 ), leptin ( 18 ) and glucagon-like peptide-1 (GLP-1) ( 19 ) are involved in the control of food intake in the LPBN. Besides, our recent research showed that administration of anorexia peptide nesfatin-1 in rats’ LPBN could modulate food

Open access

Helle Keinicke, Gao Sun, Caroline M Junker Mentzel, Merete Fredholm, Linu Mary John, Birgitte Andersen, Kirsten Raun, and Marina Kjaergaard

recognized as metabolic regulatory molecules. Stimulation of the BA receptor TGR5 increases EE in BAT as well as GLP-1 secretion in the intestinal L-cells ( 53 ). Also, in gastric bypass patients, increased BA has been suggested to contribute to the improved

Open access

Adrian F Daly, Liliya Rostomyan, Daniela Betea, Jean-François Bonneville, Chiara Villa, Natalia S Pellegata, Beatrice Waser, Jean-Claude Reubi, Catherine Waeber Stephan, Emanuel Christ, and Albert Beckers

, dipeptiyl peptidase-4 (DPP-4) inhibitors, a sulfonylurea and GLP-1 agonists. HbA1c was eventually brought down to <7% with the addition of insulin glargine. With chronic treatment using pasireotide LAR 40 mg/month, IGF-1 levels continually trended downwards

Open access

Pernille H Hellmann, Jonatan I Bagger, Katrine R Carlander, Katrine B Hansen, Julie L Forman, Joachim Størling, Elizaveta Chabanova, Jens Holst, Tina Vilsbøll, and Filip K Knop

and glucagon responses, but unaltered GLP-1 response after intervention with steroid hormone, relative physical inactivity, and high-calorie diet in healthy subjects . Journal of Clinical Endocrinology and Metabolism 2011 96 447 – 453 . ( https

Open access

Hong Wang, Jie Cao, Jian-bin Su, Xue-qin Wang, Dong-mei Zhang, and Xiao-hua Wang

alone, insulin treatments, insulin-secretagogues, pioglitazone, α-glucosidase inhibitors (AGIs), glucagon-like peptide-1 receptor agonists (GLP-1RAs) and dipeptidyl peptidase 4 inhibitors (DPP-4Is). The BMI was calculated as the ratio of the weight (kg

Open access

Tsuneo Ogawa and Adolfo J de Bold

ANF and its sensitivity to PTX (46) . An involvement of glucagon-like peptide-1 (GLP1) has recently been implicated in the regulation of ANF secretion from the heart. GLP1 is one of the incretin hormones secreted from endocrine cells located in the

Open access

Cecília Cristelo, Alexandra Machado, Bruno Sarmento, and Francisco Miguel Gama

Diabetes Association . Diabetes Care 2015 38 1964 – 1974 . ( ) 21 Doggrell SA Do glucagon-like peptide-1 receptor (GLP-1R) agonists have potential as adjuncts in the treatment of type 1 diabetes? Expert Opinion

Open access

Melinda Kertész, Szilárd Kun, Eszter Sélley, Zsuzsanna Nagy, Tamás Kőszegi, and István Wittmann

decreasing insulin resistance (e.g. sodium-glucose cotransporter-2 inhibitors or GLP-1 receptor agonists) on the T3. There are some other important data related to the T3 level and T3/T4 ratio in obese patients ( 32 ). After 6 months of gastric banding of

Open access

Anna C Simcocks, Kayte A Jenkin, Lannie O’Keefe, Chrishan S Samuel, Michael L Mathai, Andrew J McAinch, and Deanne H Hryciw

), adiponectin (AdipoGen, Liestal, Switzerland), glucagon-like peptide 1 (GLP-1), ghrelin, leptin (Bioplex hormone immunoassay; Bio-Rad Laboratories), erythropoietin (EPO), growth regulated α protein/keratinocyte chemoattractant (GROC/KC), interferon gamma (IFN